Morningstar lifts Ebos share value, earnings forecast on Chemist Warehouse deal

Morningstar lifts Ebos share value, earnings forecast on Chemist Warehouse deal
Margreet Dietz
By Margreet Dietz July 4 (BusinessDesk) - Shares of Ebos Group earned an upgrade from Morningstar analyst Chris Kallos after the pharmaceutical and animal health products maker unexpectedly won a distribution deal from Australia's Chemist Warehouse. In a note dated July 2, Kallos said he raised Ebos' fair value estimate to $20 a share, up from $19 a share previously, following “the surprise move” by Chemist Warehouse to switch suppliers from Sigma Healthcare, effective July 1, 2019.  Shares of Christchurch-based Ebos jumped 6.5 percent...